Assertio Holdings Inc ASRT:NASDAQ

Last Price$3.15NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change+0.20(6.78%)
Bid (Size)$3.15 (1)
Ask (Size)$3.19 (5)
Day Low / High$2.94 - 3.22
Volume1.9 M

View Pharmaceuticals: Major IndustryPeer Comparison as of 07/01/2022


Assertio Holdings Inc ( NASDAQ )

Price: $3.15
Change: +0.20 (6.78%)
Volume: 1.9 M
4:00PM ET 7/01/2022

Spectrum Pharmaceuticals Inc ( NASDAQ )

Price: $0.77
Change: -0.01 (1.33%)
Volume: 1.7 M
4:00PM ET 7/01/2022

Viracta Therapeutics Inc ( NASDAQ )

Price: $3.67
Change: -0.21 (5.41%)
Volume: 231.8 K
4:00PM ET 7/01/2022

Fennec Pharmaceuticals Inc ( NASDAQ )

Price: $5.71
Change: +0.13 (2.33%)
Volume: 35.7 K
4:00PM ET 7/01/2022

scPharmaceuticals Inc ( NASDAQ )

Price: $4.88
Change: +0.06 (1.24%)
Volume: 27.3 K
4:00PM ET 7/01/2022

Read more news Recent News

--BWS Financial Initiates Assertio Therapeutics at Buy, $6 Price Target
12:06PM ET 5/18/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (ASRT) ASSERTIO HOLDINGS Reports Q1 Revenue $36.5M, vs. Street Est of $33.1M
4:11PM ET 5/09/2022 MT Newswires


-- Earnings Flash (ASRT) ASSERTIO HOLDINGS Posts Q1 EPS $0.38
4:10PM ET 5/09/2022 MT Newswires


-- Earnings Flash (ASRT) ASSERTIO HOLDINGS Posts Q4 Revenue $33.3M, vs. Street Est of $30.8M
8:30AM ET 3/09/2022 MT Newswires


Company Profile

Business DescriptionAssertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. Its commercial portfolio of branded products focuses on the following areas: neurology, hospital, and pain and inflammation. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL. View company web site for more details
Address100 South Saunders Road
Lake Forest, Illinois 60045
Number of Employees116
Recent SEC Filing05/16/20224
President, Chief Executive Officer & DirectorDaniel A. Peisert
Senior Vice President-OperationsWilliam Iskos
Chief Financial Officer & Senior Vice PresidentPaul Schwichtenberg
Chief Accounting Officer & Senior Vice PresidentAjay Patel

Company Highlights

Price Open$2.95
Previous Close$2.95
52 Week Range$0.85 - 3.52
Market Capitalization$143.1 M
Shares Outstanding45.4 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/04/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings52.50
Earnings per Share$0.09
Beta vs. S&P 500N/A
Revenue$311.8 M
Net Profit Margin2.68%
Return on Equity3.21%

Analyst Ratings as of 05/17/2022

Consensus RecommendationConsensus Icon
Powered by Factset